ALPHA TEKNOVA, INC. Financing Cash Flow
ALPHA TEKNOVA, INC. (TKNO) reported Financing Cash Flow of $136.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Financing Activities
us-gaap:NetCashProvidedByUsedInFinancingActivities · last filed 2026-08-06
- ALPHA TEKNOVA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-06-30 was $224.00K.
- ALPHA TEKNOVA, INC. net cash provided by (used in) financing activities for the quarter ending 2026-03-31 was -$88.00K.
- ALPHA TEKNOVA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-12-31 was -$37.00K.
- ALPHA TEKNOVA, INC. net cash provided by (used in) financing activities for the quarter ending 2025-09-30 was $268.00K, a 98.26% decline year-over-year.
- ALPHA TEKNOVA, INC. net cash provided by (used in) financing activities for fiscal 2025 was $151.00K, a 98.99% decline from fiscal 2024.
- ALPHA TEKNOVA, INC. net cash provided by (used in) financing activities for fiscal 2024 was $14.89M, a 16.34% increase from fiscal 2023.
- ALPHA TEKNOVA, INC. net cash provided by (used in) financing activities for fiscal 2023 was $12.80M, a 24.66% increase from fiscal 2022.
- ALPHA TEKNOVA, INC. net cash provided by (used in) financing activities for fiscal 2022 was $10.27M, a 90.73% decline from fiscal 2021.
| Period end | Net Cash Provided by (Used in) Financing Activities 3 month | Net Cash Provided by (Used in) Financing Activities 6 month | Net Cash Provided by (Used in) Financing Activities 9 month | Net Cash Provided by (Used in) Financing Activities 12 month |
|---|---|---|---|---|
| 2026-06-30 | $224.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | $136.00K 10-Q · filed 2026-08-06 | $99.00K derived: sum of 3 quarters · filed 2026-08-06 | $367.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$88.00K 10-Q · filed 2026-05-07 | -$125.00K derived: sum of 2 quarters · filed 2026-05-07 | $143.00K derived: sum of 3 quarters · filed 2026-05-07 | $115.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$37.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $231.00K derived: sum of 2 quarters · filed 2026-03-02 | $203.00K derived: sum of 3 quarters · filed 2026-08-06 | $151.00K 10-K · filed 2026-03-02 |
| 2025-09-30 | $268.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $240.00K derived: sum of 2 quarters · filed 2026-08-06 | $188.00K 10-Q · filed 2025-11-07 | $101.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$28.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-06 | -$80.00K 10-Q · filed 2026-08-06 | -$167.00K derived: sum of 3 quarters · filed 2026-08-06 | $15.20M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$52.00K 10-Q · filed 2026-05-07 | -$139.00K derived: sum of 2 quarters · filed 2026-05-07 | $15.23M derived: sum of 3 quarters · filed 2026-05-07 | $15.18M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$87.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-02 | $15.28M derived: sum of 2 quarters · filed 2026-03-02 | $15.23M derived: sum of 3 quarters · filed 2026-03-02 | $14.89M 10-K · filed 2026-03-02 |
| 2024-09-30 | $15.37M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $15.32M derived: sum of 2 quarters · filed 2025-11-07 | $14.98M 10-Q · filed 2025-11-07 | $14.36M derived: sum of 4 quarters · filed 2025-11-07 |
| 2024-06-30 | -$47.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | -$390.00K 10-Q · filed 2025-08-08 | -$1.01M derived: sum of 3 quarters · filed 2025-08-08 | $12.61M derived: sum of 4 quarters · filed 2025-08-08 |
| 2024-03-31 | -$343.00K 10-Q · filed 2025-05-09 | -$964.00K derived: sum of 2 quarters · filed 2025-05-09 | $12.66M derived: sum of 3 quarters · filed 2025-05-09 | $12.48M derived: sum of 4 quarters · filed 2025-05-09 |
| 2023-12-31 | -$621.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $13.00M derived: sum of 2 quarters · filed 2025-03-07 | $12.82M derived: sum of 3 quarters · filed 2025-03-07 | $12.80M 10-K · filed 2025-03-07 |
| 2023-09-30 | $13.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $13.45M derived: sum of 2 quarters · filed 2024-11-08 | $13.42M 10-Q · filed 2024-11-08 | $18.56M derived: sum of 4 quarters · filed 2024-11-08 |
| 2023-06-30 | -$180.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-13 | -$205.00K 10-Q · filed 2024-08-13 | $4.93M derived: sum of 3 quarters · filed 2024-08-13 | $4.97M derived: sum of 4 quarters · filed 2024-08-13 |
| 2023-03-31 | -$25.00K 10-Q · filed 2024-05-13 | $5.12M derived: sum of 2 quarters · filed 2024-05-13 | $5.15M derived: sum of 3 quarters · filed 2024-05-13 | $10.19M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $5.14M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $5.17M derived: sum of 2 quarters · filed 2024-03-27 | $10.21M derived: sum of 3 quarters · filed 2024-03-27 | $10.27M 10-K · filed 2024-03-27 |
| 2022-09-30 | $35.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $5.07M derived: sum of 2 quarters · filed 2023-11-13 | $5.13M 10-Q · filed 2023-11-13 | $5.13M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $5.04M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $5.09M 10-Q · filed 2023-08-11 | $5.09M derived: sum of 3 quarters · filed 2023-08-11 | $3.83M derived: sum of 4 quarters · filed 2023-08-11 |
| 2022-03-31 | $55.00K 10-Q · filed 2023-05-11 | $54.00K derived: sum of 2 quarters · filed 2023-05-11 | -$1.21M derived: sum of 3 quarters · filed 2023-05-11 | $100.57M derived: sum of 4 quarters · filed 2023-05-11 |
| 2021-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-30 | -$1.27M derived: sum of 2 quarters · filed 2023-03-30 | $100.52M derived: sum of 3 quarters · filed 2023-03-30 | $110.79M 10-K · filed 2023-03-30 |
| 2021-09-30 | -$1.26M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $100.52M derived: sum of 2 quarters · filed 2022-11-14 | $110.79M 10-Q · filed 2022-11-14 | $110.79M derived: sum of 4 quarters · filed 2022-11-14 |
| 2021-06-30 | $101.78M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-11 | $112.06M 10-Q · filed 2022-08-11 | $112.06M derived: sum of 3 quarters · filed 2022-08-11 | $110.50M derived: sum of 4 quarters · filed 2022-08-11 |
| 2021-03-31 | $10.28M 10-Q · filed 2022-05-12 | $10.28M derived: sum of 2 quarters · filed 2022-05-12 | $8.72M derived: sum of 3 quarters · filed 2022-05-12 | |
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-18 | -$1.55M derived: sum of 2 quarters · filed 2022-03-18 | -$1.60M 10-K · filed 2022-03-18 | |
| 2020-09-30 | -$1.55M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$1.60M 10-Q · filed 2021-11-12 | ||
| 2020-06-30 | -$45.00K 10-Q · filed 2021-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |